GlassScriptPhysician profile
Brittany Shaffer
NPI 1356963300
$887.27
in general payments reported to CMS, 2019-2025
21 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.22 · 2022: $61.03 · 2023: $48.36 · 2024: $454 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $83.15 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $82.75 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $70.44 | 2022-2024 | Mounjaro, Jardiance, Zepbound |
| Mylan Specialty L.P. | $67.64 | 2024 | Yupelri |
| Dexcom, INC. | $62.48 | 2022-2025 | Dexcom G6 Transmitter |
| Dendreon Pharmaceuticals LLC | $60.58 | 2021-2024 | Provenge |
| Astrazeneca Pharmaceuticals LP | $60.16 | 2024-2025 | Airsupra, Breztri |
| Abbvie INC. | $57.11 | 2023-2025 | |
| Pfizer INC. | $51.63 | 2024 | |
| Indivior INC. | $46.82 | 2024 | Sublocade |
| Inspire Medical Systems, INC. | $38.59 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.14 | 2023-2025 | Synjardy, Tradjenta, Jardiance |
| Novo Nordisk INC | $30.49 | 2024-2025 | Ozempic, Rybelsus |
| Alkermes, INC. | $25.63 | 2024 | Vivitrol |
| Amgen INC. | $19.08 | 2025 | Repatha, Otezla |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.04 | 2025 | Inceptiv |
| Boston Scientific Corporation | $17.50 | 2025 | Watchman Flx |
| Organon LLC | $17.23 | 2023 | Nexplanon, Nuvaring |
| Insulet Corporation | $15.94 | 2024 | Omnipod |
| Regeneron Healthcare Solutions, INC. | $15.31 | 2025 | Evkeeza |
| Lundbeck LLC | $14.56 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Shaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.